Skip to main content

Table 4 Prediction performance of BCPMD in the internal, external and prospective validation cohorts

From: A novel explainable online calculator for contrast-induced AKI in diabetics: a multi-centre validation and prospective evaluation study

BCPMD

AUC (%) (95% CI)

Accuracy (%) (95% CI)

Sensitivity (%)

(95% CI)

Specificity (%)

(95% CI)

PPV (%)

(95% CI)

NPV (%)

(95% CI)

F1 score (%)

(95% CI)

Internal validation performance

81.93

(78.25–85.46)

81.76

(79.22–84.46)

54.21

(46.49–62.39)

87.84

(85.41–90.04)

49.57

(41.98–57.14)

89.68

(87.37–91.98)

51.79

(45.33–58.33)

External validation performance

80.48

(75.49–85.03)

76.90

(74.01–79.78)

70.00

(60.98–78.38)

78.06

(75.00–81.01)

35.00

(29.05–41.21)

93.91

(91.69–95.84)

46.67

(40.00–53.15)

Prospective validation performance

80.08

(68.83–88.70)

82.56

(77.91–86.63)

68.42

(50.00–84.62)

84.31

(79.31–88.74)

35.14

(21.88–48.48)

95.56

(92.41–97.92)

46.43

(31.11–58.62)

  1. BCPMD brief CIAKI prediction model for diabetes, AUC area under the curve, PPV positive predictive value, NPV negative predictive value, 95% CI 95% confidence interval